M

Moderna

1171 employees

Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.

Investor insights

Sectors invested in

Biotechnology5
Therapeutics4
Machine Learning2
Artificial Intelligence2
Health Care2
TCR-based Immunotherapies1
Medical1
TCR Discovery1
Standardized PBMC collection1
Immunomonitoring1
TCR Bispecifics1
Peptidomics & mass spectrometry1
Rare Disease1
Genetics1
ceDNA Genetic Medicine1
Bispecific Development1
Cancer1
Discovery of HLA-restricted tumor-associated peptides as cancer targets1
Biomarkers1
Immunology1

Funding rounds participated in

$88M sweet spot round size

Most of their 5 investments are in rounds between $20M and $100M

Investor type

Investment Bank

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Genetics
Medical
Pharmaceutical
Biotechnology and mRNA Therapeutics

Date founded

2010

Investments made

I

Immatics Biotechnologies raised undisclosed on September 11, 2023

Investors: Moderna

G

Generation Bio raised $76M on March 23, 2023

Investors: Moderna

M

Metagenomi raised $100M on January 5, 2023

Investors: Novo Holdings, Leaps by Bayer, Catalio Capital Management and Moderna

M

Metagenomi raised $175M on January 25, 2022

Investors: Partner Fund Management, Pura Vida Investments, Millennium Partners, Surveyor Capital, YAYA Capital, Novo Holdings, Leaps by Bayer, Marshall Wace, RA Capital Management, L.P. and Moderna

O

Onkaido Therapeutics raised $20M on January 14, 2014

Investors: Moderna

Funding rounds raised

Total raised

$500M

from 18 investors over 18 rounds

M

Moderna raised $250M on October 12, 2022

Investors: MSD Capital

M

Moderna raised $472M on July 26, 2020

Investors: Biomedical Advanced Research and Development Authority (BARDA)

M

Moderna raised $483M on April 17, 2020

Investors: Biomedical Advanced Research and Development Authority (BARDA)

M

Moderna raised $125M on May 3, 2018

Investors: Merck Group

M

Moderna raised $500M on February 1, 2018

Investors: Sequoia Capital China, Julius Baer, Abu Dhabi Investment Authority (ADIA), EDBI Pte Ltd, Viking Global Investors and Pictet Asset Management

M

Moderna raised $8M on September 7, 2016

Investors: Biomedical Advanced Research and Development Authority (BARDA)

M

Moderna raised $20M on January 12, 2016

Investors: Bill & Melinda Gates Foundation

M

Moderna raised $450M on January 5, 2015

Investors: Viking Global Investors, The Invus Group, RA Capital Management, L.P., Alexion Pharmaceuticals, Inc. and Wellington Management

M

Moderna raised $25M on January 14, 2014

Investors: Alexion Pharmaceuticals, Inc.

FAQ